CTNM
Contineum Therapeutics Inc.
$11.01
+$0.47(+4.46%)
45
Overall
60
Value
30
Tech
--
Quality
Market Cap
$309.30M
Volume
82.43K
52W Range
$3.35 - $20.24
Target Price
$22.33
EPS Estimates Overview
| Current Quarter | $-0.58 | Next Quarter | $-0.61 |
| Current Year | $-2.39 | Next Year | $-2.47 |
| QoQ Growth | -5.2% | YoY Growth | -3.3% |
| 3Y EPS CAGR | N/A | Target Price | $22.33 |
| Consensus | Buy | Upside | +102.8% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CTNM | $11.01 | +4.5% | 82.43K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Contineum Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW